The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Despite Controversy, Human Studies of CRISPR Move Forward in the U.S.

    Article obtained from Scientific American RSS Feed.

    The technology that produced a global scandal in China last year has entered into clinical trials to treat sickle cell anemia and an eye disease

    — Read more on ScientificAmerican.com

    Aug, 13 2019 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.